Medicare受益者中孤立CABG时外科医生冠状动脉内膜剥脱倾向与生存结局的关系
该回顾性队列纳入2001–2019年接受孤立CABG的1 500 710例Medicare受益者,其中32 302例(2.2%)同期行冠状动脉内膜剥脱(CE)。按CE频率将外科医生分为从不、偶尔和频繁三组,经重叠倾向评分加权风险调整后,从不或偶尔行CE的外科医生治疗的患者早期风险调整生存略有优势,远期结局相似。
要点
- CE在孤立CABG中占2.2%,不同外科医生CE频率差异大。
- 从不或偶尔行CE的外科医生治疗者风险调整中位生存略优于频繁行CE者。
- CE仍是选择性病例的重要工具,但采用从不或偶尔CE策略可能合理。
核心结论
- 由从不或偶尔行CE的外科医生行CABG的患者,较频繁行CE者有小幅早期风险调整生存优势,远期结局相似。
研究设计与样本
- 回顾性队列研究,纳入2001–2019年Medicare受益者中接受孤立CABG的1 500 710例,按外科医生CE频率五分位分层,采用重叠倾向评分加权进行风险调整。
主要发现
- 32 302例(2.2%)行同期CE;从不CE组267 245例手术(1839名医生),偶尔CE组1 001 310例(2207名医生),频繁CE组232 155例(756名医生)。
- 从不CE组风险调整中位生存10.05年(95%CI 10.00–10.09),频繁CE组9.90年(9.86–9.95),差异1.71个月(95%CI 1.08–2.37),P<0.001。
- 偶尔CE组风险调整中位生存9.94年(9.91–9.96),频繁CE组9.85年(9.80–9.90),差异1.05个月(95%CI 0.56–1.74),P<0.001。
关键数值与推荐
- 外科医生按CE频率分为:从不(0%)、偶尔(0–4%)、频繁(≥4%)。
临床怎么用
- CE仍是选择性弥漫性冠状动脉病变病例的有效血运重建辅助手段。
- 外科医生在CABG中采用从不或偶尔CE策略可能是合理的。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Coronary endarterectomy (CE) is an adjunct to coronary artery bypass grafting (CABG) in patients with one or more diffusely diseased coronary arteries. Although associated with increased perioperative morbidity and mortality, it remains a therapeutic strategy to potentially improve late outcomes by facilitating the revascularization of an otherwise ungraftable target. METHODS: Medicare beneficiaries undergoing CABG from 2001 to 2019 were identified. Surgeon proclivity for endarterectomy was determined; surgeons were stratified by quintile of endarterectomy frequency. Overlap propensity score weighting risk-adjusted measured confounding variables. Risk-adjusted survival was compared between surgeons. RESULTS: 1 500 710 Medicare beneficiaries underwent isolated CABG, of whom 32 302 (2.2%) underwent concomitant CE. Surgeons were divided into never-endarterectomizers (0% frequency, 267 245 surgeries by 1839 surgeons), occasional-endarterectomizers (0-4% frequency, 1 001 310 surgeries by 2207 surgeons) and frequent-endarterectomizers (≥4% frequency, 232 155 surgeries by 756 surgeons). Beneficiaries undergoing surgery by a never-endarterectomizer had a risk-adjusted median survival of 10.05 [95% CI: 10.00, 10.09] versus 9.90 [9.86, 9.95] years in those undergoing surgery by a frequent-endarterectomizer, a difference of 1.71 [1.08, 2.37] months, P < 0.001 for risk-adjusted survival comparison. Similarly, beneficiaries undergoing surgery by an occasional-endarterectomizer had a risk-adjusted median survival of 9.94 [9.91, 9.96] versus 9.85 [9.80, 9.90] years for those undergoing surgery by a frequent-endarterectomizer, a difference of 1.05 [0.56, 1.74] months, P < 0.001 for risk-adjusted survival comparison. CONCLUSIONS: Medicare beneficiaries undergoing CABG by never- or occasional-endarterectomizers had small early risk-adjusted survival advantages and similar late outcomes compared to those undergoing surgery by frequent-endarterectomizers. CE remains a valuable tool in selected cases; however, it may be reasonable for surgeons to adopt a never- or occasional-endarterectomy approach to CABG.
引用
- Eisenga JB, McCullough KA, Kluis A, et al. Surgeon proclivity for coronary endarterectomy during isolated coronary artery bypass grafting in Medicare beneficiaries†. Eur J Cardiothorac Surg. 2025. PMID: 40080711. doi:10.1093/ejcts/ezaf064
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。